Potential Therapeutic Approach of Melatonin against Omicron and Some Other Variants of SARS-CoV-2
暂无分享,去创建一个
M. Yagi | Y. Yonei | A. Mamun-Or-Rashid | B. K. Sil | Priti Tagde | Md. Kamruzzaman Pramanik | N. Mukerjee | R. Begum | Tanzima Tarannum Lucy | Nobendu Mukerjee
[1] M. Grover,et al. The COVID-19 Pandemic and Post-Infection Irritable Bowel Syndrome: What Lies Ahead for Gastroenterologists , 2022, Clinical Gastroenterology and Hepatology.
[2] Corey D. Fogleman,et al. A Pilot of a Randomized Control Trial of Melatonin and Vitamin C for Mild-to-Moderate COVID-19 , 2022, The Journal of the American Board of Family Medicine.
[3] Mehrnoush Dianatkhah,et al. High dose melatonin as an adjuvant therapy in intubated patients with COVID-19: A randomized clinical trial , 2022, Journal of Taibah University Medical Sciences.
[4] A. Sehirli,et al. Melatonin and REGN-CoV2 combination as a vaccine adjuvant for Omicron variant of SARS-CoV-2 , 2022, Molecular Biology Reports.
[5] T. Mizutani,et al. Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization , 2022, Microbiology spectrum.
[6] P. Bellavite,et al. A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Management of Mild-to-Moderate Symptomatic COVID-19 , 2022, Medical science monitor : international medical journal of experimental and clinical research.
[7] A. Molina-Carballo,et al. Protective Effect of Melatonin Administration against SARS-CoV-2 Infection: A Systematic Review , 2021, Current issues in molecular biology.
[8] G. Cheng,et al. Sequence analysis of the emerging SARS‐CoV‐2 variant Omicron in South Africa , 2021, Journal of medical virology.
[9] F. Rodríguez‐Artalejo,et al. Pharmacological treatment of COVID-19: an opinion paper , 2021, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.
[10] Z. T. Hasan,et al. The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients , 2021, International Journal of Infectious Diseases.
[11] G. Mannino,et al. Melatonin and Phytomelatonin: Chemistry, Biosynthesis, Metabolism, Distribution and Bioactivity in Plants and Animals—An Overview , 2021, International journal of molecular sciences.
[12] A. Nath,et al. Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease , 2021, Brain : a journal of neurology.
[13] Yun Wang,et al. The Effects of Aβ1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2 , 2021, International journal of molecular sciences.
[14] S. Amar,et al. Mitochondrial Modulations, Autophagy Pathways Shifts in Viral Infections: Consequences of COVID-19 , 2021, International journal of molecular sciences.
[15] Computational and spectroscopy study of melatonin , 2021, Indian Journal of Chemistry -Section B.
[16] A. Cossarizza,et al. Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19 , 2021, Cells.
[17] S. Ghavami,et al. Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses , 2021, International journal of molecular sciences.
[18] P. Fasinu,et al. Clinical Management of COVID-19: A Review of Pharmacological Treatment Options , 2021, Pharmaceuticals.
[19] Gholamreza Farnoosh,et al. Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment , 2021, European Journal of Pharmacology.
[20] Y. Kwon,et al. COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development , 2021, Archives of Pharmacal Research.
[21] P. Boor,et al. Cell-Type Apoptosis in Lung during SARS-CoV-2 Infection , 2021, Pathogens.
[22] G. Bayhan,et al. Impact of COVID-19 on serum melatonin levels and sleep parameters in children , 2021, Turkish journal of medical sciences.
[23] D. Gozal,et al. Predictive factors of insomnia during the COVID-19 pandemic in Bangladesh: a GIS-based nationwide distribution , 2021, Sleep Medicine.
[24] J. DiNicolantonio,et al. Melatonin may decrease risk for and aid treatment of COVID-19 and other RNA viral infections , 2021, Open Heart.
[25] A. Othman,et al. Melatonin exerts a neuroprotective effect against γ-radiation-induced brain injury in the rat through the modulation of neurotransmitters, inflammatory cytokines, oxidative stress, and apoptosis , 2021, Environmental Science and Pollution Research.
[26] R. Reiter,et al. Role of Melatonin on Virus-Induced Neuropathogenesis—A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 Infection , 2021, Antioxidants.
[27] I. Carvacho,et al. RGD‐binding integrins and TGF‐β in SARS‐CoV‐2 infections – novel targets to treat COVID‐19 patients? , 2021, Clinical & translational immunology.
[28] P. Boor,et al. Cell-type apoptosis in lung during SARS-CoV-2 infection , 2020, bioRxiv.
[29] Gholamreza Farnoosh,et al. Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial , 2020, Archives of Medical Research.
[30] B. Chernyak,et al. COVID-19 and Oxidative Stress , 2020, Biochemistry (Moscow).
[31] B. Crespi,et al. Conflicts over calcium and the treatment of COVID-19 , 2020, Evolution, medicine, and public health.
[32] Z. Xia,et al. Gastrointestinal Symptoms Associated With Unfavorable Prognosis of COVID-19 Patients: A Retrospective Study , 2020, Frontiers in Medicine.
[33] G. Bellastella,et al. Faculty Opinions recommendation of Melatonin: Roles in influenza, COVID-19, and other viral infections. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[34] A. Helenius,et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity , 2020, Science.
[35] N. Tatonetti,et al. Melatonin is significantly associated with survival of intubated COVID-19 patients , 2020, medRxiv.
[36] Yu Tang,et al. Revisiting the Immune Balance Theory: A Neurological Insight Into the Epidemic of COVID-19 and Its Alike , 2020, Frontiers in Neurology.
[37] J. Farrés,et al. In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm , 2020, PloS one.
[38] F. Pallardó,et al. Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression , 2020, Antioxidants.
[39] F. Nikbakht,et al. How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms , 2020, Multiple Sclerosis and Related Disorders.
[40] I. Alquisiras-Burgos,et al. Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection , 2020, Molecular Neurobiology.
[41] D. Wang,et al. Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications , 2020, Molecular neurobiology.
[42] Hyun-Dong Chang,et al. In severe COVID-19, SARS-CoV-2 induces a chronic, TGF-β-dominated adaptive immune response , 2020, medRxiv.
[43] Danylo César Correia Palmeira,et al. Headache and pleocytosis in CSF associated with COVID-19: case report , 2020, Neurological Sciences.
[44] R. Reiter,et al. Melatonin as a putative protection against myocardial injury in COVID-19 infection , 2020, Expert review of clinical pharmacology.
[45] A. Hosseinzadeh,et al. Melatonin potentials against viral infections including COVID-19: Current evidence and new findings , 2020, Virus Research.
[46] M. Fung,et al. Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer's disease , 2020, Annals of the New York Academy of Sciences.
[47] C. Socaciu,et al. Melatonin, an ubiquitous metabolic regulator: functions, mechanisms and effects on circadian disruption and degenerative diseases , 2020, Reviews in Endocrine and Metabolic Disorders.
[48] K. Bhaskaran,et al. OpenSAFELY: factors associated with COVID-19 death in 17 million patients , 2020, Nature.
[49] A. Othman,et al. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19 , 2020, European Journal of Pharmacology.
[50] K. Girish,et al. Melatonin restores neutrophil functions and prevents apoptosis amid dysfunctional glutathione redox system , 2020, Journal of pineal research.
[51] D. Léger,et al. Covid‐19 health crisis and lockdown associated with high level of sleep complaints and hypnotic uptake at the population level , 2020, Journal of sleep research.
[52] Keshav K. Singh,et al. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis , 2020, Mitochondrion.
[53] Yang Han,et al. The ORF3a protein of SARS-CoV-2 induces apoptosis in cells , 2020, Cellular & Molecular Immunology.
[54] G. Corbi,et al. COVID-19 and the elderly: insights into pathogenesis and clinical decision-making , 2020, Aging Clinical and Experimental Research.
[55] R. Reiter,et al. Plasticity of glucose metabolism in activated immune cells: advantages for melatonin inhibition of COVID-19 disease , 2020 .
[56] R. Reiter,et al. Melatonin as adjuvant treatment for coronavirus disease 2019 pneumonia patients requiring hospitalization (MAC-19 PRO): a case series , 2020 .
[57] D. Cardinali. High doses of melatonin as a potential therapeutic tool for the neurologic sequels of covid-19 infection , 2020 .
[58] Fei Zhou. Clinical Course And Risk Factors For Mortality Of Adult In Patients With COVID-19 In Wuhan, China: A Retrospective Cohort Study , 2020 .
[59] C. Ruiz,et al. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease , 2020, Cytokine & Growth Factor Reviews.
[60] Thomas P. Clements,et al. A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2 , 2020, The FEBS journal.
[61] M. Mori,et al. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis , 2020, Cell Metabolism.
[62] J. Hussman. Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention , 2020, Frontiers in Pharmacology.
[63] R. Reiter,et al. Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment , 2020, Life Sciences.
[64] A. Wells,et al. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy , 2020, The Lancet Respiratory Medicine.
[65] Cezmi A Akdis,et al. Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19 , 2020, Allergy.
[66] M. Merad,et al. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages , 2020, Nature Reviews Immunology.
[67] F. López-Muñoz,et al. Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin? , 2020, Cellular and Molecular Neurobiology.
[68] S. Tokajian,et al. SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis , 2020, mSystems.
[69] Derouiche Samir. Oxidative Stress Associated with SARS-Cov-2 (COVID-19) Increases the Severity of the Lung Disease - A Systematic Review , 2020 .
[70] L. Delgado-Roche,et al. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection , 2020, Archives of Medical Research.
[71] M. Ntyonga-Pono. COVID-19 infection and oxidative stress: an under-explored approach for prevention and treatment? , 2020, The Pan African medical journal.
[72] R. Reiter,et al. Melatonin: Roles in influenza, Covid‐19, and other viral infections , 2020, Reviews in medical virology.
[73] Yan Zhao,et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 , 2020, Journal of Infection.
[74] Stefano Pascarella,et al. Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy , 2020, Journal of Infection.
[75] Huanhuan Gao,et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera , 2020, Cell.
[76] Dingding Shen,et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? , 2020, The Lancet Neurology.
[77] Suresh Patel,et al. COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features , 2020, Radiology.
[78] Dean P. Jones,et al. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents , 2020, Nature Reviews Molecular Cell Biology.
[79] Lanjuan Li,et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms , 2020, Gut.
[80] R. Reiter,et al. COVID-19: Melatonin as a potential adjuvant treatment , 2020, Life Sciences.
[81] Zhaohui Zheng,et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein , 2020, bioRxiv.
[82] R. Reiter,et al. Treatment of ebola and other infectious diseases: melatonin “goes viral” , 2020 .
[83] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[84] W. Liao,et al. Melatonin Promotes Nerve Regeneration Following End-to-Side Neurorrhaphy by Accelerating Cytoskeletal Remodeling via the Melatonin Receptor-dependent Pathway , 2020, Neuroscience.
[85] P. Mehta,et al. COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.
[86] Tsutomu Hashikawa,et al. The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients , 2020, Journal of medical virology.
[87] Lei Liu,et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury , 2020, Science China Life Sciences.
[88] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[89] Daniel J Klionsky,et al. Autophagy and SARS-CoV-2 infection: A possible smart targeting of the autophagy pathway , 2020, Virulence.
[90] A. Molina-Carballo,et al. Possible Protective Role of Melatonin in Pediatric Infectious Diseases and Neurodevelopmental Pathologies , 2020, Journal of Child Science.
[91] S. Tufik,et al. Influence of Dietary Sources of Melatonin on Sleep Quality: A Review. , 2019, Journal of food science.
[92] F. López-Muñoz,et al. Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics , 2019, Cancers.
[93] F. Scheer,et al. Impact of Circadian Disruption on Cardiovascular Function and Disease , 2019, Trends in Endocrinology & Metabolism.
[94] J. Arendt. Melatonin: Countering Chaotic Time Cues , 2019, Front. Endocrinol..
[95] H. Shan,et al. Melatonin prevents lung injury by regulating apelin 13 to improve mitochondrial dysfunction , 2019, Experimental & Molecular Medicine.
[96] Yunzhao Hu,et al. Inhibitory effect of melatonin on Mst1 ameliorates myocarditis through attenuating ER stress and mitochondrial dysfunction , 2019, Journal of Molecular Histology.
[97] P. Pinton,et al. Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care , 2019, Cell Death & Disease.
[98] A. Keshavarzian,et al. Circadian rhythms: a regulator of gastrointestinal health and dysfunction , 2019, Expert review of gastroenterology & hepatology.
[99] Lijuan Hu,et al. Melatonin Alleviates Radiation-Induced Lung Injury via Regulation of miR-30e/NLRP3 Axis , 2019, Oxidative medicine and cellular longevity.
[100] Meredith C Rogers,et al. Reining in the CD8+ T cell: Respiratory virus infection and PD-1-mediated T-cell impairment , 2019, PLoS pathogens.
[101] Chunxiang Zhang,et al. Melatonin Ameliorates Coxsackievirus B3-Induced Myocarditis by Regulating Apoptosis and Autophagy , 2018, Front. Pharmacol..
[102] A. Hacışevki,et al. An Overview of Melatonin as an Antioxidant Molecule: A Biochemical Approach , 2018, Melatonin - Molecular Biology, Clinical and Pharmaceutical Approaches.
[103] J. Cipolla-Neto,et al. Melatonin as a Hormone: New Physiological and Clinical Insights. , 2018, Endocrine reviews.
[104] L. R. Aps,et al. The Combined Use of Melatonin and an Indoleamine 2,3-Dioxygenase-1 Inhibitor Enhances Vaccine-Induced Protective Cellular Immunity to HPV16-Associated Tumors , 2018, Front. Immunol..
[105] Jianfeng Zhang,et al. RETRACTED: MicroRNA-494 inhibition alleviates acute lung injury through Nrf2 signaling pathway via NQO1 in sepsis-associated acute respiratory distress syndrome , 2018, Life Sciences.
[106] S. Perlman,et al. Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis , 2018, mBio.
[107] H. Shan,et al. Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway , 2018, International journal of molecular sciences.
[108] Younho Choi,et al. Autophagy during viral infection — a double-edged sword , 2018, Nature Reviews Microbiology.
[109] B. Alghamdi. The neuroprotective role of melatonin in neurological disorders , 2018, Journal of neuroscience research.
[110] R. Reiter,et al. Melatonin: A Versatile Protector against Oxidative DNA Damage , 2018, Molecules.
[111] Rodrigo Sandoval,et al. TNF-α Increases Production of Reactive Oxygen Species through Cdk5 Activation in Nociceptive Neurons , 2018, Front. Physiol..
[112] Feng Zhang,et al. Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP/HIF‐1α signaling , 2018, Journal of cellular biochemistry.
[113] M. de Gasparo,et al. Diurnal opposite variation between angiotensinase activities in photo–neuro–endocrine tissues of rats , 2017, Chronobiology international.
[114] P. Muti,et al. Melatonin and Hippo Pathway: Is There Existing Cross-Talk? , 2017, International journal of molecular sciences.
[115] S. Yun,et al. Melatonin Rescues Mesenchymal Stem Cells from Senescence Induced by the Uremic Toxin p-Cresol via Inhibiting mTOR-Dependent Autophagy , 2017, Biomolecules & therapeutics.
[116] R. Reiter,et al. Melatonin protects against lipid‐induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice , 2017, Journal of pineal research.
[117] Rachana D Sharma,et al. Melatonin inhibits snake venom and antivenom induced oxidative stress and augments treatment efficacy. , 2017, Acta tropica.
[118] Jie Xiao,et al. Melatonin attenuates angiotensin II-induced cardiomyocyte hypertrophy through the CyPA/CD147 signaling pathway , 2016, Molecular and Cellular Biochemistry.
[119] E. Latz,et al. Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition , 2016, Scientific Reports.
[120] T. Mak,et al. TNF and ROS Crosstalk in Inflammation. , 2016, Trends in cell biology.
[121] C. Sasakawa,et al. Molecular mechanisms regulating NLRP3 inflammasome activation , 2015, Cellular and Molecular Immunology.
[122] M. Álvarez-Mon,et al. Melatonin, minocycline and ascorbic acid reduce oxidative stress and viral titers and increase survival rate in experimental Venezuelan equine encephalitis , 2015, Brain Research.
[123] Hao Li,et al. Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation , 2015, Autophagy.
[124] Y. Quiroz,et al. Melatonin decreases brain apoptosis, oxidative stress, and CD200 expression and increased survival rate in mice infected by Venezuelan equine encephalitis virus , 2015, Antiviral chemistry & chemotherapy.
[125] J. Dudka,et al. Protective effects of melatonin against thioacetamide-induced liver fibrosis in rats. , 2015, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[126] C. Tocharus,et al. Melatonin Protects Methamphetamine-Induced Neuroinflammation Through NF-κB and Nrf2 Pathways in Glioma Cell Line , 2015, Neurochemical Research.
[127] Seung-Chul Hong,et al. The Impact of Sleep and Circadian Disturbance on Hormones and Metabolism , 2015, International journal of endocrinology.
[128] Haifeng Jin,et al. Melatonin attenuates hypoxic pulmonary hypertension by inhibiting the inflammation and the proliferation of pulmonary arterial smooth muscle cells , 2014, Journal of pineal research.
[129] Kui Li,et al. Coronavirus membrane-associated papain-like proteases induce autophagy through interacting with Beclin1 to negatively regulate antiviral innate immunity , 2014, Protein & Cell.
[130] H. Yip,et al. Melatonin augments apoptotic adipose-derived mesenchymal stem cell treatment against sepsis-induced acute lung injury. , 2014, American journal of translational research.
[131] S. Phipps,et al. Soluble Heparan Sulfate Fragments Generated by Heparanase Trigger the Release of Pro-Inflammatory Cytokines through TLR-4 , 2014, PloS one.
[132] Yiqiang Zhang,et al. Melatonin: a well‐documented antioxidant with conditional pro‐oxidant actions , 2014, Journal of pineal research.
[133] Jung-whan Kim,et al. Regulation of Wound Healing and Fibrosis by Hypoxia and Hypoxia-Inducible Factor-1 , 2014, Molecules and cells.
[134] J. Prieto,et al. Melatonin modulates the autophagic response in acute liver failure induced by the rabbit hemorrhagic disease virus , 2014, Journal of pineal research.
[135] R. Reiter,et al. Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology. , 2014, Human reproduction update.
[136] I. Komuro,et al. Melatonin ameliorates Angiotensin II‐induced vascular endothelial damage via its antioxidative properties , 2013, Journal of pineal research.
[137] N. Johns,et al. Serum melatonin levels and antioxidant capacities after consumption of pineapple, orange, or banana by healthy male volunteers , 2013, Journal of pineal research.
[138] R. Bravo,et al. Tryptophan-enriched cereal intake improves nocturnal sleep, melatonin, serotonin, and total antioxidant capacity levels and mood in elderly humans , 2013, AGE.
[139] M. Halgamuge,et al. Pineal melatonin level disruption in humans due to electromagnetic fields and ICNIRP limits. , 2013, Radiation protection dosimetry.
[140] R. Reiter,et al. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK , 2013, Journal of pineal research.
[141] R. Reiter,et al. Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin's primary function and evolution in eukaryotes , 2013, Journal of pineal research.
[142] R. Reiter,et al. A review of the molecular aspects of melatonin’s anti‐inflammatory actions: recent insights and new perspectives , 2013, Journal of pineal research.
[143] M. Pozo,et al. Aging-induced alterations in female rat colon smooth muscle: the protective effects of hormonal therapy , 2012, Journal of Physiology and Biochemistry.
[144] Hsin-Chen Lee,et al. Melatonin attenuates kainic acid‐induced neurotoxicity in mouse hippocampus via inhibition of autophagy and α‐synuclein aggregation , 2012, Journal of pineal research.
[145] M. Abdollahi,et al. Melatonin, a promising supplement in inflammatory bowel disease: a comprehensive review of evidences. , 2011, Current pharmaceutical design.
[146] M. Pozo,et al. Melatonin, and to a lesser extent growth hormone, restores colonic smooth muscle physiology in old rats , 2011, Journal of pineal research.
[147] S. Dikalov. Cross talk between mitochondria and NADPH oxidases. , 2011, Free radical biology & medicine.
[148] R. Reiter,et al. Melatonin as a natural ally against oxidative stress: a physicochemical examination , 2011, Journal of pineal research.
[149] Sun-Mee Lee,et al. Melatonin protects liver against ischemia and reperfusion injury through inhibition of toll‐like receptor signaling pathway , 2011, Journal of pineal research.
[150] P. Konturek,et al. Gut clock: implication of circadian rhythms in the gastrointestinal tract. , 2011, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[151] Nicholas C. Ide,et al. The ClinicalTrials.gov results database--update and key issues. , 2011, The New England journal of medicine.
[152] J. Prieto,et al. Melatonin attenuates apoptotic liver damage in fulminant hepatic failure induced by the rabbit hemorrhagic disease virus , 2011, Journal of pineal research.
[153] D. Acuña-Castroviejo,et al. Melatonin, a potential therapeutic agent for smooth muscle-related pathological conditions and aging. , 2010, Current medicinal chemistry.
[154] W. Coward,et al. The pathogenesis of idiopathic pulmonary fibrosis , 2010, Therapeutic advances in respiratory disease.
[155] Francesco Galli,et al. Melatonin signaling and cell protection function , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[156] R. Reiter,et al. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines , 2009, Journal of pineal research.
[157] Paolo Bernardi,et al. Pathophysiology of mitochondrial volume homeostasis: potassium transport and permeability transition. , 2009, Biochimica et biophysica acta.
[158] Thomas Korn,et al. IL-17 and Th17 Cells. , 2009, Annual review of immunology.
[159] P. Terry,et al. Melatonin and ulcerative colitis: Evidence, biological mechanisms, and future research , 2009, Inflammatory bowel diseases.
[160] F. Peyrot,et al. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species , 2008, Journal of pineal research.
[161] M. Pozo,et al. Age‐related alterations in Ca2+ signals and mitochondrial membrane potential in exocrine cells are prevented by melatonin , 2008, Journal of pineal research.
[162] P. Hellstrand,et al. Melatonin restores impaired contractility in aged guinea pig urinary bladder , 2008, Journal of pineal research.
[163] Chengyu Jiang,et al. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway , 2008, Cell Research.
[164] L. Steardo,et al. Melatonin reverses lipopolysaccharide‐induced gastro‐intestinal motility disturbances through the inhibition of oxidative stress , 2007, Journal of pineal research.
[165] R. Reiter,et al. One molecule, many derivatives: A never‐ending interaction of melatonin with reactive oxygen and nitrogen species? , 2007, Journal of pineal research.
[166] M. Itoh,et al. Expression and cellular localization of melatonin‐synthesizing enzymes in the rat lens , 2007, Journal of pineal research.
[167] M. Pozo,et al. Melatonin Treatment Reverts Age-Related Changes in Guinea Pig Gallbladder Neuromuscular Transmission and Contractility , 2006, Journal of Pharmacology and Experimental Therapeutics.
[168] Nicholas M. Radio,et al. Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy , 2006, Journal of pineal research.
[169] Hiroaki Masaki,et al. Affective-motivational influences on feedback-related ERPs in a gambling task , 2006, Brain Research.
[170] R. Reiter,et al. The modulatory role of melatonin on immune responsiveness. , 2006, Current opinion in investigational drugs.
[171] D. Cardinali,et al. The role of melatonin in immuno‐enhancement: potential application in cancer , 2006, International journal of experimental pathology.
[172] C. Ekmekcioglu. Melatonin receptors in humans: biological role and clinical relevance. , 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[173] S. Perlman,et al. Immunopathogenesis of coronavirus infections: implications for SARS , 2005, Nature Reviews Immunology.
[174] G. Buonocore,et al. Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment , 2005, Journal of pineal research.
[175] R. Reiter,et al. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages , 2005, Journal of Neuroimmunology.
[176] B. Jaber,et al. Immune‐Modulating Effects of Melatonin, N‐Acetylserotonin, and N‐Acetyldopamine , 2005, Annals of the New York Academy of Sciences.
[177] M. Dubocovich,et al. Functional MT1 and MT2 melatonin receptors in mammals , 2005, Endocrine.
[178] R. Reiter,et al. A review of the multiple actions of melatonin on the immune system , 2005, Endocrine.
[179] Josep M. Guerrero,et al. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[180] Vijayalaxmi,et al. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. , 2004, Polish journal of pharmacology.
[181] S. Medina-Leendertz,et al. Melatonin and viral infections , 2004, Journal of pineal research.
[182] Josep M. Guerrero,et al. Melatonin counteracts the inhibitory effect of PGE2 on IL‐2 production in human lymphocytes via its mt1 membrane receptor , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[183] Takashi Taguchi,et al. Pulmonary fibrosis: Cellular and molecular events , 2003, Pathology international.
[184] G. Bubenik. REVIEW: Gastrointestinal Melatonin: Localization, Function, and Clinical Relevance , 2002, Digestive Diseases and Sciences.
[185] D. Tobin,et al. Serotoninergic and melatoninergic systems are fully expressed in human skin , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[186] E. Moore,et al. Acute Hypoxemia in Humans Enhances the Neutrophil Inflammatory Response , 2002, Shock.
[187] R. Reiter,et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. , 2002, Current topics in medicinal chemistry.
[188] S. Paludan,et al. Molecular Pathways in Virus-Induced Cytokine Production , 2001, Microbiology and Molecular Biology Reviews.
[189] G. Maestroni,et al. Evidence for melatonin synthesis in mouse and human bone marrow cells , 2000, Journal of pineal research.
[190] S. Weintraub,et al. Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. , 1999, Biochimica et biophysica acta.
[191] S. Reppert. Melatonin Receptors: Molecular Biology of a New Family of G Protein-Coupled Receptors , 1997, Journal of biological rhythms.
[192] I. Antolín,et al. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[193] R. Reiter,et al. Oxidative processes and antioxidative defense mechanisms in the aging brain 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[194] H. Illnerová,et al. Melatonin rhythm in human milk. , 1993, The Journal of clinical endocrinology and metabolism.
[195] G. Benítez-King,et al. Calmodulin mediates melatonin cytoskeletal effects , 1993, Experientia.
[196] C. Rodríguez,et al. 5-Aminolevulinate synthase mRNA levels in the Harderian gland of Syrian hamsters: Correlation with porphyrin concentrations and regulation by androgens and melatonin , 1991, Molecular and Cellular Endocrinology.
[197] G. Benítez-King,et al. Melatonin modifies calmodulin cell levels in MDCK and N1E-115 cell lines and inhibits phosphodiesterase activity in vitro , 1991, Brain Research.
[198] G. Maestroni,et al. Role of the pineal gland in immunity Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone , 1986, Journal of Neuroimmunology.
[199] R. Reiter,et al. Rhythms in immunoreactive melatonin in the retina and Harderian gland of rats: persistence after pinealectomy. , 1983, Life sciences.
[200] R. Reiter,et al. Melatonin: A potential therapeutic agent against COVID-19 , 2021 .
[201] S. Comai,et al. Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology. , 2014, Journal of psychiatry & neuroscience : JPN.
[202] R. Reiter,et al. Medical implications of melatonin: receptor-mediated and receptor-independent actions. , 2007, Advances in medical sciences.
[203] G. Bubenik. Localization of melatonin in the digestive tract of the rat. Effect of maturation, diurnal variation, melatonin treatment and pinealectomy. , 1980, Hormone research.